Cardiotrack, a pioneering provider of data-centric healthcare screening technology and services, has raised $2 million in a pre-series A funding round. Girish Narasimhan led the round, with co-investment from Y S Shashidhar. This marks a significant milestone in the company’s growth trajectory.
This latest infusion of capital follows a previous angel investment round totalling $1.6 million from a select group of UHNIs, underlining investor confidence in Cardiotrack’s innovative approach to healthcare screening.
Founded by Avin Agarwal, Cardiotrack is at the forefront of delivering cutting-edge pathology and radiology screening services directly to individuals’ homes. With a vast network spanning over 300 locations across India, the company leverages its advanced technology to provide convenient and accessible healthcare solutions to its health and life insurance customers.
At the heart of Cardiotrack’s offerings is its unique screening technology, which replicates the experience of a treadmill test within the comfort of one’s home. Combined with video-based medical examinations, the company’s medical-grade diagnostic devices and workflow automation solutions empower individuals to manage their health proactively.
Moreover, Cardiotrack’s comprehensive health data digitization platform provides valuable insights into consumers’ health profiles, enabling informed decision-making for individuals and healthcare providers. Currently serving nine significant health and life insurance companies in India, the Bengaluru-based startup is poised to drive transformative change in the healthcare industry.
With this latest funding injection, Cardiotrack aims to enhance its technological capabilities further, expand its service offerings, and broaden its reach to empower even more individuals to prioritize their health and well-being. As the demand for convenient and personalized healthcare solutions continues to rise, Cardiotrack stands ready to lead the charge towards a healthier future for all.
